Yeon Hee Park
0000-0003-4156-9212
3 papers found
Refreshing results…
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
Pembrolizumab for Early Triple-Negative Breast Cancer
Missing publications? Search for publications with a matching author name.